FDA Approved Use of Xarelto
In 2011, the FDA approved Xarelto’s use as a blood thinner for patients who have had knee or hip replacement surgery to reduce the risk of blood clots and for reducing the risk of stroke in people with an irregular heartbeat. It was also approved for the general treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
No Proper Warnings: Uncontrollable Bleeding
Uncontrollable bleeding is a risk shared by all blood thinners; however, older, more traditional drugs such as Warfarin have an emergency antidote to prevent serious bleeding problems. Xarelto does not and cannot be flushed out of one’s system; thus, the uncontrollable bleeding can be fatal.
A number of serious side effects have been attributed to Xarelto, including:
- Death caused by uncontrolled bleeding
- Rectal bleeding
- Intestinal bleeding
- Brain hemorrhaging
- Blood clots
- Abnormal liver function
Xarelto has been linked to 130 deaths and 1,700 complications in Germany (January 2012 to September 2013). In addition, 680 serious adverse events attributed to Xarelto were reported to the FDA in 2013.
Taking Action Against Pharmaceutical Companies
Bayer and Janssen Pharmaceuticals, Inc., the makers of Xarelto, have been accused of producing a dangerous and defective drug, not testing it thoroughly enough before putting it on the market, and failing to warn doctors and patients of this dangerous side effect.
It’s time to hold pharmaceutical companies accountable for the drugs they produce. The lawyers at Nash & Franciskato Law Firm are ready to help you take legal action against these companies to obtain compensation for your pain and suffering.
Litigation is in the early stages and an MDL has been established, meaning that it may take some time before any trials or settlements are reached. However, it is never too soon to seek the advice and guidance of a personal injury attorney.
Receive a Free Evaluation
Take Action Today. If you or a loved one suffered a serious bleeding event after taking Xarelto, contact the Nash & Franciskato Law Firm for a free, no-obligation case evaluation.
Because of the large number of lawsuits filed, in December 2014, the U.S. Judicial Panel on Multidistrict Litigation consolidated these cases into a multidistrict litigation (MDL).
An MDL helps simplify the process because a number of cases can be handled by the same experienced judge and in the same court. People whose lawsuits become a part of an MDL keep their own lawyers, and their suits are still handled as individual cases.
The Xarelto MDL is being held in front of U.S. District Judge Eldon Fallon in the Eastern District of Louisiana.